Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 24, 2026 07:30 ET | Source: Alveus Therapeutics Inc

Alveus Therapeutics Announces Second and Final Closing of Oversubscribed Series A, Bringing Total Financing to $197 Million to Advance Next‑Generation Therapies for Obesity and Metabolic Diseases

Jeito Capital, Novo Holdings and other healthcare investors join Series A syndicate led by New Rhein Healthcare Investors, Andera Partners, and Omega FundsAdditional capital further supports clinical...
February 05, 2024 10:04 ET | Source: Wohl & Fruchter LLP

CTLT Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Catalent to Novo Holdings

We are investigating the fairness of the sale of Catalent to Novo Holdings for $63.50 per share in cash.